SCHEMBL7848892

SCHEMBL7848892

Cc1cccc(C(=O)O)c1NC(=O)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.60
KDM4E B2RXH2 3/20 0.59
ALDH1A1 P00352 3/20 0.52
HPGD P15428 3/20 0.52
HSD17B10 Q99714 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.50
ACLY P53396 1/20 0.49
MYC P01106 1/20 0.47
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
AKR1B10 O60218 1/20 0.46
TRPA1 O75762 1/20 0.46
ABCB11 O95342 1/20 0.46
DHFR P00374 1/20 0.46
LMNA P02545 1/20 0.46
MPO P05164 1/20 0.46
CYP1A2 P05177 1/20 0.46
CHRM1 P11229 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3729817 0.87 ALDH1A1 (0.63) POLBALDH1A1L3MBTL1CYP3A4CYP2C9
SCHEMBL950942 0.84 POLB (0.62) POLBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL18757942 0.81 POLB (0.58) POLBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL10363338 0.81 POLB (0.58) POLBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7985663 0.80 PTPN11 (0.55) POLBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL165558 0.79 POLB (0.61) POLBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL11665956 0.79 KDM4E (0.78) POLBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL9958891 0.79 POLB (0.60) POLBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL14057915 0.79 POLB (0.57) POLBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL14058700 0.79 POLB (0.57) POLBKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225329-B1 USEFUL IN THE TREATMENT OF TYPE I DIABETES, TYPE II DIABETES, IMPAIRED GLUCOSE TOLERANCE, INSULIN AUTOIMMUNITY DISEASES WITH DYSFUNCTIONS OF THE COAGULATION SYSTEM, ALLERGIC DISEASES NOVO NORDISK A/S (DK) 2001-05-01 US disclosed
EP-1080068-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES Novo Nordisk A/S (DK) 2001-03-07 EP disclosed
WO-1999046237-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed